In this new research paper, Maetrics details the $16.5BN competitive market advantage for medtech firms that move quickly to comply with the new European Medical Device Regulation (MDR).

The MDR is designed to improve both clinical safety and fair market access for all medtech players, but a rapidly emerging capacity shortage both among Notified Bodies – tasked with certification – and expert compliance staff and consultants, means that manufacturers may find themselves unable to complete compliance across their product portfolios by the statutory deadline if they delay their preparations.